Sign In
News Digest /
StockInvest.us
Author: StockInvest.us
08:15am, Thursday, Aug 14, 2025
Snapshot - Biotricity Inc. (OTCBB: BTCY)
What's happening inside the company (quick view):
- Revenue momentum: revenue grew to $3,873,993 for Q1 (June 30, 2025) from $3,201,743 a year earlier (≈+21%).
- Mix shift to recurring tech fees: technology fees $3,371,392 (87% of revenue) vs device sales ...
08:14am, Thursday, Aug 14, 2025
Protalix BioTherapeutics, Inc. (NYSE: PLX)
Quick facts - latest quarter / six months (from Form 10‑Q ended June 30, 2025)
* Total revenue (six months): $25,771
* Revenues from selling goods (six months): $25,435
* Cost of goods sold (six months): $(14,050) - gross profit = $11,721
* R&D (six mont...
08:13am, Thursday, Aug 14, 2025
Rockwell Medical, Inc. (NASDAQ: RMTI) - Q2 2025 snapshot
Quick take
* Revenue is sliding sharply after losing material volume from a major customer (DaVita).
* Management says liquidity is sufficient for at least 12 months, but the company still depends on access to capital (ATM facility) and exe...
08:12am, Thursday, Aug 14, 2025
Cellectar Biosciences, Inc. (NASDAQ: CLRB)
Quick take: management is cutting spending after finishing enrollment in its pivotal CLOVER WaM study, has FDA Breakthrough Therapy designation for iopofosine I‑131, but remains capital‑constrained with a formal going‑concern warning and material weaknes...
08:11am, Thursday, Aug 14, 2025
Chicago Atlantic BDC, Inc. (NASDAQ: SSIC) - Quick read on what's happening inside the company
Snapshot / headline
- The company's June 30, 2025 10‑Q shows a materially larger operating platform after the October 1, 2024 Loan Portfolio Acquisition. Investment income and net investment income have ...
08:09am, Thursday, Aug 14, 2025
Werewolf Therapeutics, Inc. (NASDAQ: HOWL)
Quick read - what's happening inside the company and what the income statement says.
Key facts and figures (from 10‑Q, amounts presented in the filing):
* Cash and cash equivalents (June 30, 2025): $77,596
* Total cash, cash equivalents and restricted ca...
08:08am, Thursday, Aug 14, 2025
BK Technologies Corporation (NYSEARCA: BKTI) - quick take
What's happening inside:
BK is executing its manufacturing transition and new product rollout (BKR series and BKR9000). Management is expanding a Solutions unit (BK ONE) with SaaS and interoperability products while continuing radio hardwa...
08:07am, Thursday, Aug 14, 2025
Prelude Therapeutics Incorporated (NASDAQ: PRLD) - quick status update
What's happening inside:
- The company remains a clinical‑stage biopharma focused on targeted cancer therapies (SMARCA degraders, KAT6A degraders, CDK9 inhibitor, precision ADCs).
- Active collaborations and licensing: multi‑p...
08:06am, Thursday, Aug 14, 2025
Falcon's Beyond Global, Inc. (NASDAQ: FBYD) - Q2 2025 quick take
Short verdict: the company shows a large GAAP net income driven by equity‑method gains (PDP transaction), a much stronger cash balance after a one‑time distribution, but operating results and liquidity carry material risks (working ...
08:05am, Thursday, Aug 14, 2025
Advanced Flower Capital Inc. (NASDAQ: AFCG)
Quick summary - what's happening inside the company
* The company is an externally managed mortgage REIT focused on loans to cannabis operators; the Board approved (Aug 12, 2025) an expanded investment mandate and is pursuing shareholder approval to con...
08:04am, Thursday, Aug 14, 2025
Abeona Therapeutics Inc. (NASDAQ: ABEO) - What's happening inside the company
Abeona received FDA approval for ZEVASKYN™ on April 28, 2025, sold the associated Priority Review Voucher (PRV) for gross proceeds of $155.0 million (closed June 27, 2025), has established cGMP commercial manufacturing ...
08:03am, Thursday, Aug 14, 2025
Snapshot - Onconetix, Inc. (NASDAQ: BWV)
What's happening inside: management has pivoted to commercializing Proclarix (Proteomedix acquisition) while abandoning ENTADFI commercialization; the company faces acute liquidity stress and repeated forbearance/waivers with creditor Veru. A potential mer...
08:02am, Thursday, Aug 14, 2025
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) - What's happening inside the company (quick, factual summary)
Snapshot / liquidity & capital:
* Cash and cash equivalents (June 30, 2025): $35.48 million (reported in thousands).
* Investments in U.S. Treasury securities (current + non-current): $117.026 m...
08:01am, Thursday, Aug 14, 2025
Galectin Therapeutics Inc. (NASDAQ: GALT) - What's happening inside
Straight to the point: the company is winding down its large NAVIGATE clinical spend, improving near‑term cash burn, but remains highly levered to related‑party financing and dependent on new capital. Clinical data are mixed - en...
07:14am, Thursday, Aug 14, 2025
StandardAero, Inc. (NYSE: SARO) - Quick snapshot (what's happening inside)
The company is growing revenue and recovering profitability after refinancing its capital structure in 2024. Operational momentum shows in higher Adjusted EBITDA and segment performance, but the business still carries heav...